Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A drug for inhibiting hepatitis B virus in the body of hepatitis B virus carriers

A hepatitis B virus carrier technology, applied in antiviral agents, pharmaceutical formulations, plant raw materials, etc., to achieve the effect of taking less medicine, improving prognosis, and reducing HBV-DNA content

Inactive Publication Date: 2011-12-21
王法根
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] At present, there are interferon, lamivudine and other western medicines that have therapeutic effect on hepatitis B virus, and their characteristics are as follows: 1. Most of them have curative effect; 2. Drug withdrawal 3. There are side effects such as elevated transaminases; 4. The course of treatment is longer and the cost is higher

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] Embodiment 1: Take by weighing 300 grams of Daqingye, 300 grams of Comfrey, 600 grams of Polygonum cuspidatum, 300 grams of rhubarb, 600 grams of burdock, and 900 grams of Ganoderma lucidum, first crush the rhubarb and burdock, and pass through a 100-mesh sieve; Leaves, comfrey, knotweed, and ganoderma lucidum were boiled in 10 kg of pure water for 40 minutes, filtered through fine gauze, and the filtrate was reserved. Put the second dregs into 10 kg of pure water and decoct for 30 minutes, filter with fine gauze, combine the three filtrates, concentrate into a paste, then add rhubarb and arctium powder into the paste, mix well, and dry , crushed, and packed into zero-size capsules, each capsule containing 0.4 grams of medicine.

Embodiment 2

[0026] Embodiment 2: In this embodiment, use 900 grams of Folium Folium, 600 grams of Comfrey, 900 grams of Polygonum cuspidatum, 600 grams of Rhubarb, 1800 grams of Burdock, and 1800 grams of Ganoderma lucidum. Others are the same as in Example 1.

Embodiment 3

[0027] Embodiment 3: In this embodiment, use 600 grams of Folium Folium, 450 grams of Comfrey, 750 grams of Polygonum cuspidatum, 450 grams of Rhubarb, 1200 grams of Burdock, and 1350 grams of Ganoderma lucidum. Others are the same as in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine for inhibiting hepatitis B virus in the body of a hepatitis B virus carrier, which is prepared from the following raw materials in parts by weight: Daqingye 3-9, Lithospermica 3-6, Polygonum cuspidatum 6-9, Rhubarb 3-6 , Arctium 6-18, Ganoderma lucidum 9-18. The invention has the effects of clearing away heat and detoxifying, cooling blood and removing pathogenic factors. For hepatitis B virus carriers, it can inhibit the replication of hepatitis B virus in patients, reduce the HBV-DNA content in peripheral blood, and help improve the quality of life and prognosis of hepatitis B virus carriers. The present invention also has the advantages of less dosage and times of taking, and low treatment cost.

Description

technical field [0001] The invention belongs to pharmaceutical preparations, in particular to a medicine for inhibiting hepatitis B virus in the body of a hepatitis B virus carrier made from pure traditional Chinese medicine. Background technique [0002] At present, there are interferon, lamivudine and other western medicines that have a therapeutic effect on hepatitis B virus, and their characteristics are: 1. Most of them have curative effect; 2. There is rebound after stopping the drug; 3. There are side effects such as elevated transaminase; The course of treatment is longer and the cost is higher. It should be noted that, for hepatitis B virus carriers, no matter in terms of symptoms, signs and liver function tests, they are normal. Once the liver function is abnormal and the transaminase increases, it means that he has become a hepatitis B patient. Contents of the invention [0003] The purpose of the present invention is to provide a medicine for inhibiting th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/708A61K9/48A61P31/20
Inventor 王法根
Owner 王法根
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com